PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
55.22
ESG score 90-95% of Biotechnology median of 60.59. John Neff would demand higher returns to compensate for below-average ESG risk management.
51.62
Environmental score 90-95% of Biotechnology median of 56.33. John Neff would demand higher returns to compensate for below-average climate risk management.
56.90
Social score 80-90% of Biotechnology median of 64.44. Martin Whitman would look for hidden social liabilities and reputational risks.
57.14
Governance score 80-90% of Biotechnology median of 63.56. Martin Whitman would look for hidden agency costs and management entrenchment risks.